HSU-PING KUO,Hsin-Kang Hsieh,Betty Y. Chang,Ling Xue,Sriram Balasubramanian,Leo Cheung
申请号：
US15656394
公开号：
US20180071295A1
申请日:
2017.07.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed herein are methods, compositions, and kits for treating a B-cell malignancy comprising administering a combination of a BTK inhibitor (e.g. ibrutinib) and a PIM inhibitor. Also disclosed herein are methods, compositions, and kits for treating a BTK-resistant B-cell malignancy comprising administering a combination of a BTK inhibitor (e.g. ibrutinib) and a PIM inhibitor.
